Table II.
Compliance of each item of the Preferred Reporting Items for Systematic Reviews and Meta-analyses checklist
| PRISMA item | Adequate | Adequate, % | Inadequate | Inadequate, % | Not described | Not described, % | N/A | N/A, % | Total possible minus N/A | Studies adequately reporting each item when applicable, % |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 | 166 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 166 | 100 |
| 26 | 166 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 166 | 100 |
| 14 | 69 | 42 | 0 | 0 | 3 | 2 | 94 | 57 | 72 | 96 |
| 6 | 154 | 93 | 0 | 0 | 12 | 7 | 0 | 0 | 166 | 93 |
| 9 | 153 | 92 | 0 | 0 | 13 | 8 | 0 | 0 | 166 | 92 |
| 1 | 150 | 90 | 0 | 0 | 16 | 10 | 0 | 0 | 166 | 90 |
| 25 | 150 | 90 | 0 | 0 | 16 | 10 | 0 | 0 | 166 | 90 |
| 11 | 149 | 90 | 0 | 0 | 17 | 10 | 0 | 0 | 166 | 90 |
| 20 | 148 | 89 | 9 | 5 | 9 | 5 | 0 | 0 | 166 | 89 |
| 27 | 147 | 89 | 0 | 0 | 18 | 11 | 1 | 1 | 165 | 89 |
| 23 | 48 | 29 | 0 | 0 | 6 | 4 | 112 | 67 | 54 | 89 |
| 2 | 147 | 89 | 0 | 0 | 19 | 11 | 0 | 0 | 166 | 89 |
| 7 | 147 | 89 | 0 | 0 | 19 | 11 | 0 | 0 | 166 | 89 |
| 21 | 64 | 39 | 0 | 0 | 9 | 5 | 93 | 56 | 73 | 88 |
| 17 | 140 | 84 | 0 | 0 | 26 | 16 | 0 | 0 | 166 | 84 |
| 13 | 114 | 69 | 0 | 0 | 29 | 17 | 23 | 14 | 143 | 80 |
| 4 | 130 | 78 | 36 | 22 | 0 | 0 | 0 | 0 | 166 | 78 |
| 18 | 129 | 78 | 0 | 0 | 37 | 22 | 0 | 0 | 166 | 78 |
| 10 | 126 | 76 | 0 | 0 | 40 | 24 | 0 | 0 | 166 | 76 |
| 8 | 111 | 67 | 0 | 0 | 55 | 33 | 0 | 0 | 166 | 67 |
| 15 | 45 | 27 | 0 | 0 | 27 | 16 | 94 | 57 | 72 | 63 |
| 16 | 44 | 27 | 0 | 0 | 28 | 17 | 94 | 57 | 72 | 61 |
| 24 | 88 | 53 | 78 | 47 | 0 | 0 | 0 | 0 | 166 | 53 |
| 19 | 54 | 33 | 0 | 0 | 112 | 67 | 0 | 0 | 166 | 33 |
| 22 | 44 | 27 | 58 | 35 | 63 | 38 | 1 | 1 | 165 | 27 |
| 12 | 39 | 23 | 28 | 17 | 99 | 60 | 0 | 0 | 166 | 23 |
| 5 | 25 | 15 | 21 | 13 | 120 | 72 | 0 | 0 | 166 | 15 |
PRISMA items 3 and 26 had 100% compliance, whereas PRISMA items 5 and 12 had the least compliance.
PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-analyses.